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ABSTRACT
Acute postoperative pain is a complex, physiological reaction to tissue injury. It remains a
challenge for anesthesia providers and health care practitioners to create a balanced multimodal
approach to treat it. Ineffective management such as undertreatment and overtreatment of
postoperative pain leads to poor patient outcomes. Emerging as a favorable option in clinical
practice is the use of Intrathecal Morphine (ITM) before induction of general anesthesia. It is a
simpler and quicker neuraxial technique with a lower rate of failure. 1
Morphine was the first opioid approved by the US Food and Drugs Administration (FDA)
for spinal administration, and it is also the most common epidural opioid used.1 ITM is now
deemed by many as the gold-standard single-dose neuraxial opioid and is extensively used in the
perioperative setting due to improved analgesia, greater duration of action, and dose-sparing
effects compared with its administration via the systemic route.1,2
BACKGROUND
Introduction
Hospitalization often requires pain management for trauma-related injuries, for
underlying conditions such as cancer or in the post-surgical setting. Moreover, evidence suggests
that inadequate management of acute pain, which was recognized as an issue beginning in the
1990s, can progress to chronic pain.6 Opioids provide effective dose-dependent pain relief with
minimal toxic effects and can be administered via various delivery systems, including oral,
parenteral, transdermal, epidural, and spinal.2 However, there is an increasing report of errors in
the acute postoperative pain management, prescribing, and inadequate monitoring of patients on
opioid therapy leading to serious side effects and adverse events.7 Despite guidelines
recommending prudent prescribing and monitoring of hospitalized patients who are receiving
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opioids, evidence suggests that patient safety risks persist, including over-sedation leading to
respiratory depression and possible death. In addition, the widespread use in hospitals and
discharging patients on opioids can lead to long-term use, misuse, and potential dependence and
addiction.6
In response to the opioid crisis, the U.S. Department of Health and Human Services
(HHS) is focusing its efforts on five major priorities 8:
1. Improving access to treatment and recovery services
2. Promoting the use of overdose-reversing drugs
3. Strengthening our understanding of the epidemic through better public health surveillance
4. Providing support for cutting-edge research on pain and addiction
5. Advancing better practices for pain management
One of the interventions to advance better practices for pain management is the Enhanced
Recovery After Surgery (ERAS) protocol. The ERAS protocol incorporated in most healthcare
systems in the United States includes a personalized, safe, and effective pain management plan to
help prevent opioid addiction, which is an ongoing public health crisis in the United States.9
ERAS engages patients in their care before, during, and after their hospitalization.9 ERAS also
relies on collaborative care between all individuals involved in the patient’s surgical journey,
including anesthesiologists, rehabilitation therapists, nurses, and neurosurgeons, to improve
clinical outcomes and optimize a safe recovery.9 Various pain management techniques have been
adopted since the advent of ERAS to address the reduction of opioid administration during the
postoperative period. One of the techniques is the administration of single-shot intrathecal
morphine.10
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Problem Statement
Around 841,000 people have died since 1999 from a drug overdose. Moreover, in 2019,
70% of drug overdose deaths involved an opioid.5 Opioids are substances that work in the body's
nervous system or in specific receptors in the brain to reduce the intensity of pain. Overdose
deaths involving opioids, including prescription opioids, heroin, and synthetic opioids (e.g.,
fentanyl), have increased exponentially from 1999 to 2019.5The misuse of and addiction to
opioids, including prescription pain relievers, heroin, and synthetic opioids such as fentanyl, is a
severe national crisis that significantly affects public health as well as social and economic
welfare.6
The Centers for Disease Control and Prevention estimates that the total economic burden
of prescription opioid misuse alone in the United States is $78.5 billion a year, including
healthcare costs, lost productivity, addiction treatment, and criminal justice involvement.7 The
opioid epidemic in the United States has become a public health crisis with devastating
consequences, including increases in opioid misuse and related overdoses and the rising
incidence of neonatal abstinence syndrome due to opioid use and abuse during pregnancy.7 The
increase in injection drug use has also contributed to the spread of infectious diseases, including
HIV and hepatitis C.6
Scope and Consequences of the Problem
The cost of opioid abuse is not confined to health care. Many experts have estimated the
direct and indirect costs that the opioid epidemic imposes on our society. In addition to its
devastating impact on families and communities, the opioid epidemic is costing the U.S.
economy tens of billions, if not hundreds of billions, of dollars annually.6 Several studies have
provided more comprehensive estimates, including the workplace and criminal justice burdens
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attributable to the opioid crisis.6,7 Health economists Howard Birnbaum and Alan White
estimated all three categories of costs to total $8.6 billion in 2001.7 While policymakers look for
ways to stem the opioid epidemic, economists have been offering valuable insights on the impact
of the crisis on the macroeconomy.7 For example, in 2017, Princeton economist Alan Krueger
examined the relationship between opioid prescription rates per county and the decline in labor
force participation, estimating that the opioid epidemic could be responsible for 20 percent of the
decline in men’s labor force participation. Goldman Sachs economists similarly concluded that
the opioid epidemic is likely contributing to the decline in prime-age labor market participation. 5
Alex Hollingsworth and Kosali Simon from the University of Indiana and Christopher Ruhm
from the University of Virginia found that higher unemployment rates at the county level are
associated with higher opioid death rates and increased emergency room visits.5
An early 2011 analysis yielded an estimate of $53.4 billion in health care, workplace, and
criminal justice costs associated with opioid abuse in 2006.7 In 2016, CDC researchers
incorporated the cost of lost productivity from premature deaths due to opioid overdoses,
estimating the total economic impact of the opioid epidemic to be $78.5 billion in 2013.7 At the
local level, task forces have been established from New Hampshire to Alaska to understand the
local impact and identify strategies for tackling the epidemic.7 Outside of government, the
American Medical Association (AMA), various medical specialty groups, and researchers at
universities around the country are working to evaluate and develop policy interventions,
treatment options, and medical alternatives.3
One of the treatment options that reported a significant decrease in opioid requirements,
especially in the postoperative period, is the administration of single-shot intrathecal morphine.
8

A single dose of intrathecal morphine (ITM) has advantages for postoperative pain control. 8
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This approach is associated with improved quality of analgesia and decreased systemic opioid
use compared with IV-PCA alone or intrathecal local anesthetics without morphine, thus
minimizing the potential for renal toxicity, sedation, and respiratory depression. ITM has been
effectively used to control postoperative pain due to abdominal surgery, prostatectomy,
transurethral resection of the prostate, and hepatectomy.8 Although the efficacy of ITM has been
reported in many kinds of surgery, most healthcare systems in the United States have not
incorporated its use as part of their pain management protocol.
Knowledge Gaps
Morphine is a drug commonly administered via the epidural or intrathecal route.2 It is
regarded by many as the gold-standard single-dose neuraxial opioid due to its postoperative
analgesic efficacy and prolonged duration of action.11 The discovery that opioid receptors are
localized within lamina II of the dorsal horn in the CNS suggested that exogenous opioids could
be administered via the neuraxial route to produce analgesia.2 Many published reports of
intrathecal and epidural morphine administration in humans have since been published, and in
1984 preservative-free morphine received US FDA approval for neuraxial administration.11
Neuraxial morphine is now extensively used in the perioperative setting due to improved
analgesia, greater duration of action, and dose-sparing effects compared with its administration
via the systemic route.12 Analgesia delivered via the neuraxial route lasts longer than the
systemic route, with effects persisting 12–24 hours and longer following administration.2
Recognized benefits of neuraxial opioids, when compared with intravenous administration,
include better postoperative analgesia, increased functional ability, earlier ambulation, and
earlier return of bowel function.12 Furthermore, unlike with neuraxial local anesthetics, there is
negligible motor, sensory or autonomic blockade associated with neuraxial opioids.2 Neuraxial
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morphine is now extensively used in the perioperative setting due to improved analgesia, greater
duration of action, and dose-sparing effects compared with its administration via the systemic
route.
Proposal Solution
This review aims to gather available evidence and appraise each study's results regarding
the efficacy of single-shot intrathecal morphine in decreasing postoperative opioid use in patients
undergoing abdominal surgery. The proposed solution of the research is that the findings will be
incorporated in an evidence-based Enhanced Recovery after Surgery (ERAS) protocol. 8
Enhanced Recovery After Surgery (ERAS) refers to a patient-centered, evidence-based,
multidisciplinary team-developed pathways for a surgical specialty and facility culture to
minimize the patient's narcotic requirement, decrease surgical stress response, optimize their
physiologic function, and facilitate recovery. 2 This study seeks to answer the PICO (i.e., patient
population, intervention or issue of interest, comparison intervention or group, and outcome)
question: In (P) Anesthesia providers taking care of patients requiring major abdominal surgery,
(I) Intrathecal Morphine (ITM) Education Module (C) No ITM education module (O) Increase
knowledge and implementation of ITM.
Theoretical Framework
The foremost step in a research project is framework development. As the quality
improvement topic is selected, it is essential to recognize theories and frameworks to guide
theoretical ideas into application.13 A middle-range theory (MRT) framework will help conduct
this scholarly project. The middle-range theory is characterized as a theory that exemplifies the
connection among concepts to a specific situation which then can be implemented into clinical
practice.14

Page 10 of 43

Wilson et al., also stated that applying middle-range theories into research is easier
because they are testable, less abstract, simple to understand, and can be incorporated into daily
practice comprising assessments and interventions. One of the concepts in MRT is the theory of
comfort for outcomes research.14 The main idea of this theory is that healthcare professionals
meet unmet needs in stressful situations.14 The use of ITM is an evidence-based practice
intervention to reduce postoperative pain. If the intervention is proven to enhance comfort, in
comparison to baseline, it is deemed successful. Thus, sequential positive patient outcomes are
directly related to patient satisfaction and, theoretically, how MRT is applied in this scholarly
project.14
METHODOLOGY
Information Sources and Search Strategy
A systematic search for published full reports of randomized, controlled trials that
compared a single intrathecal dose (with variation of doses) of morphine with epidural
bupivacaine, a placebo subcutaneous injection of saline, or no treatment in patients undergoing
major abdominal surgery under general anesthesia. Included in this search are studies published
from 2006-2020, written in the English language, with full text availability. The databases
employed for the search included The Cumulative Index to Nursing and Allied Health Literature
(CINAHL), PubMed Central (PMC) and MEDLINE (ProQuest).
Four Randomized Control Trials (RCT) were included in the study, three RCTs were
double blinded, one single blinded RCT and one with a placebo group. All studies included adult
patients. RCTs were published between 2006 and 2020, with sample sizes ranging from 15 to 45
patients. Four different analgesic methods were assessed in comparison to intrathecal analgesia:
epidural analgesia, placebo, patient-controlled analgesia, intravenous opioid.

Page 11 of 43

A PICO format question was used to help develop the keywords and concepts used to
search each electronic database. The search terminology included block terms for (intrathecal
morphine, analgesia, major abdominal surgery), (opioid use or opioid abuse), (peri-operative or
preoperative or post-operative terms or surgery).
The literature search and screening methodology is outlined in Figure 1 in a PRISMA
flow diagram. As of 24 October 2021, the search was current. The Medline (ProQuest) database
yield 113 articles, CINAHL resulted in 142, and the PubMed database revealed 92 results. A
total of 280 articles were retrieved from all 3 databases. Duplicates were removed, leaving 78 to
be evaluated.
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Identification

Records identified through
database searching
(n = 280)

Additional records identified
through other sources
(n = 0)

Screening

Records after duplicates removed
(n =78)

Records screened
(n = 78)

Included

Eligibility

Full-text articles assessed
for eligibility
(n = 18)

Studies included in
qualitative synthesis
(n = 4)

Figure 1. PRISMA Flow Diagram
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Records excluded
(n = 130)

Full-text articles
excluded, with reasons
(n = 14)

Study Selection and Screening Method
The studies were extracted systemically and were carefully evaluated utilizing the Johns
Hopkins research evidence appraisal tool. John Hopkins' rating structure includes 5 levels of
evidence. Level 1 involves RCTs and systematic review of RCTs with or without meta-analysis.
Four Level 1 RCTs were included within the quality improvement project.
According to the John Hopkin’s rating structure, Level 2 includes quasi-experimental
studies while Level 3 are nonexperimental studies and systematic reviews of a combination of
RCTs and quasi-experimental studies. Level 4 requires the opinions of respected authorities and
nationally recognized experts of scientific evidence. And lastly, Level 5 is composed of case
reports, clinician experience, and literature reviews.
The level of evidence is also described as high, good, or low. Evidence that is deemed
high is data that is reliable, with enough control and sufficient sample size for analysis.
If it has comparatively precise outcomes with a reasonable sample size, some monitoring,
and definite conclusions, an article is considered a good ranking evidence. A 'poor' standard
ranking has no evidence with findings that are not accurate, insufficient sample size for the
analysis, and a conclusion that cannot be drawn.
Refer to Table 1 for a summary of the individual studies and describes each study’s
characteristics. Each RCT was assigned a ranking based on the John Hopkins research evaluation
tool. The information collected and assessed from each article included: (1) study type and
sample size, (2) comparing the use of ITM and its analgesic success, (4) Level of Evidence (5)
Results with dose given and time of analgesia duration.
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RESULTS AND DISCUSSION
Table 1. Summary of Individual Studies

Author Purpose
(Year)

Fares
et al
(2014)

Hein et
al
(2012)

To evaluate,
compare and
evaluate
analgesic
efficacy of
ITM 0.2 mg,
0.5 mg, and
1 mg in
patients
undergoing
major
abdominal
cancer
surgery

To explore
the
effectiveness
of adding
ITM with
varying
doses at 0,
100, 200, or
300 mcg to
intrathecal
bupivacaine
on the first

Research
Methodology
And Level of
Evidence
Randomized,
Double Blind
Control Trial
Level I

Randomized
Placebo
Double-Blind
Control Trial
Level I

Measures

Sampling

Results

Conclusions

ASA I-III cancer
patients aged 3050 years old and
scheduled for
major abdominal
surgery were
included in the
study. Excluded
were patients
with known
allergy to the
study drug and
those with
significant
systemic
disorders that
can alter the
perception and
assessment of
pain

Utilizing an
online research
randomizer,
ninety (90)
patients were
randomly
divided into
three groups
with a sample
size of (n=30)
depending on
the ITM dose
received

Group II
(ITM 0.2 mg)
respondents
showed
prolonged
request for
rescue
analgesia
(5.21 h, P <
0.001).

The trial
showed that
Group III- 1
mg dose
ITM
received
superior
analgesia for
48 hours
compared
with 0.2 mg
and 0.5 mg
ITM with a
nonsignificant
difference in
the incidence
of side
effects.

Lower
postoperative
pain scores
*Group I- ITM were
dose of 0.2 mg demonstrated
by Group II
*Group IIand Group III
ITM dose of
compared
0.5 mg
with reported
outcomes of
*Group IIIGroup I
ITM dose of
1mg
The study was
Blocked
The addition
conducted in two randomization of intrathecal
hospitals
via a
morphine to a
Danderyd
computerfixed dose of
Hospital (n=100) generated list
12 mg
And Karolinska to one of four
bupivacaine
University
groups: ITM
resulted with
Hospital (n=44) 100, 200, 300
a reduced 24between 2005
mcg or an
hour postand 2008.
equal volume, operative
1 ml of saline
morphine
(placebo) each consumption
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200 mcg
ITM as an
adjunct is
sufficient as
an opioid
sparing
treatment

postoperative
24 h patient
controlled
analgesia
consumption
after
abdominal
hysterectomy
under
general
anesthesia

Blay et
al
(2006)

Wan et
al
(2017)

To test the
hypothesis of
combining
low dose
ITM with
multimodal
post
operative
management
associated
with general
anesthesia of
patients
undergoing
abdominal
aortic
surgery

Prospective
Single Center
Double Blind
Randomized
Clinical Trial

To compare
the use of
ITM and
epidural
bupivacaine
(EB) for
their
analgesia
effectiveness
after elective

Prospective
Single
Blinded
Randomized
Controlled
Trial

Level I

Level I B

144 women
ASA I-II
between 30 and
70 years of age
scheduled for
abdominal
hysterectomy.
Patients that
were excluded
are those with
chronic pain,
ASA III-IV and
contraindications
to spinal
anesthesia or
ITM.

to be added to
hyperbaric
bupivacaine
0.5%, 2.4 ml
(12 mg) to a
total volume of
3.4 ml

A total of 42
patients
scheduled to
undergo elective
abdominal aortic
surgery were
recruited.
Patients with
chronic
respiratory
insufficiency,
coagulation
abnormalities,
infection at
puncture site and
allergies to
morphine were
excluded.

32 patients
were randomly
assigned to 2
groups.

32 patients ages
between 18-60
years old and
ASA I-II
undergoing
elective
abdominal
hysterectomy
were drafted for
this trial.
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Intraoperative
data were
comparable
between the 2
groups

Control Group
n= 16 (General Lower need
anesthesia
for
alone)
postoperative
analgesia and
ITM Group n= longer
16 (General
requests for
Anesthesia
rescue pain
plus
medication
intrathecal
for ITM
morphine)
group
compared to
the Control
group
Randomization In comparing
was done
pain levels
using a
between
computergroups, ITM
generated table revealed
of numbers to lower VAS
two equal
scores and
sized groups.
lesser
morphine
Group ITM
consumption

There is
improvement
with regards
to
postoperative
analgesia in
patients
undergoing
abdominal
aortic
surgery
when ITM is
added to
treatment

The ITM
proves to be
an excellent
alternative to
epidural
analgesia for
elective
abdominal
hysterectomy

abdominal
hysterectomy

Excluded
subjects are
those with
known allergies
to the study
drugs,
contraindications
such as
coagulation
disorder and
patients who’s
on chronic
opioid treatment
for pain

And Group EB than Group
(epidural
EB
bupivacaine,
followed by
sealing the
opaque
envelop
assignment
and opened in
the operating
room.
Single Blinded
study where
the patient and
primary
investigator
knew the
intervention
(either spinal
or epidural)

Summary of Evidence
A randomized, double-blind control trial by Fares et al., aimed to safely compare the
analgesic efficacy of intrathecal morphine (ITM) at different dosing levels for patients
undergoing major abdominal surgery. Modern advances in pharmacology and sophisticated drug
delivery systems have emerged, but a substantial 80% of postoperative patient surveys still
revealed moderate to severe pain complaints.9 Eventually, these incidents lead to delayed
recovery and prolonged hospital stay, amounting to higher costs and reduced patient satisfaction.
This study conducted the trial utilizing an online research randomizer to allocate three groups of
30 patients each to receive either 0.2 mg morphine (Group I ITM 0.2 mg), 0.5 morphine (Group
II ITM 0.5 mg), or a higher dose of 1 mg morphine (Group III ITM 1 mg).9
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The Visual Analogue Pain Scale (VAS) was employed to measure the patient's
postoperative pain level ranging from 0 to 10 (with 0 = no pain and ten = the worst pain
imaginable). 9 The process was standard for all participants; intrathecal administration of ITM
was administered in a sitting position; after cleaning the site,1.0 ml of lidocaine 2% was used to
anesthetize the landmark identified as L3-L4 interspace subsequently, the subarachnoid puncture
was performed with a 25- gauge Whitacre spinal needle.9 After administering the ITM, patients
were induced for general anesthesia utilizing fentanyl 1.5 – 2 μg/kg, propofol 2 – 3 mg/kg, and
lidocaine 1.5 mg/kg cis-atracurium 0.15 mg/kg for endotracheal tube intubation. Standard vital
signs were monitored throughout the procedure, this integrated the use of electrocardiography,
noninvasive blood pressure, SPO2%, temperature, and a Foley catheter was inserted for
measuring urine output.9 Maintenance of anesthesia was done employing isoflurane 1 – 1.5
MAC in 50% oxygen/air mixture and cis-atracurium 0.03 mg/kg bolus given every 30 minutes,
respectively.9 Reversal medications included neostigmine 50 μg/kg and atropine 20 μg/kg.
Patients were extubated and transferred to the surgical intensive care unit (SICU). SICU
monitoring was done postoperatively, then at 6, 12, 18, 24, 36, 48, 60, and 72 hours after the
procedure, inclusive of heart rate, noninvasive systolic and diastolic blood pressure, respiratory
rate, and oxygen saturation.9 Out of the one hundred and eleven patients that were screened,
ninety patients consented and enrolled with no dropouts.9 The main finding of this study is that
Group III showed the lowest VAS scores and postoperative pain medication requirements in the
first 48 hours, with a non-significant variation between doses after that.9
In contrast, Hein et al., employed a prospective randomized-placebo double-blind
controlled trial to explore the effect of low dose ITM as an adjunct to 12 mg intrathecal
Bupivacaine with post abdominal hysterectomy patients and their PCA morphine consumption in
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the first 24 hours. 10 In their investigation, a total of one hundred forty-four (144) American
Society of Anesthesiologists (ASA) I-II between 30 and 70 years of age, scheduled for
abdominal hysterectomy, were blindly distributed into four groups via a computer-generated list.
Groups were ITM 100 mcg, ITM 200 mcg, ITM 300 mcg, and an equal volume, 1 ml of saline
(Placebo Group) each to be added to hyperbaric Bupivacaine 0.5 %, 2.4 ml (12 mg) with an
aggregate volume of 3.4 ml. 10 The research drug is withheld from the patient and the medical
team engaged in their care.10 Spinal anesthesia was achieved by identifying the L3-L4, L4-L5
interspace as landmarks, confirmed by cerebrospinal fluid flow using a 25 G pencil-point
needle.10 Bupivacaine 12 mg and the study drug was administered, followed by general
anesthesia induction.10 Similar to the previous study, standard procedures in monitoring and the
VAS scale to assess pain were also used.10 Induction and maintenance medications comprised of
fentanyl 0.1 mg, propofol 2–3 mg/kg, and atracurium 0.5– 0.6 mg/kg IV and continued with a
mixture of oxygen and nitrous oxide – 30/70% with addition of sevoflurane to minimal alveolar
concentration (MAC) 1–1.5 after tracheal intubation.10 In these patients a low transverse incision
(Pfannenstiel) was done, if not, they were precluded from participating. 10 The patients were
transported to PACU post-extubation and were connected to the PCA morphine pump 1-hour
post-anesthesia end. PCA settings were as follows, boluses of 2 mg of morphine, with a lockout
time of 6 min and a 4-h maximum of 40 mg.10
Outcome measures were recorded at 1, 2, 4, 6, 12, and 24 hours postoperatively, and
primarily it quantified the total sum of morphine consumed.10 Secondary data assessed morphine
intake at varying times.10 This study concluded that ITM reduced accumulated 24 h
postoperative PCA use. 10 ITM 100 mcg considerably decreased morphine consumption vs.
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placebo for the entire 0–24-time interval post-surgery, but ITM 200 mcg substantially is more
effective. An increase to 300 mcg made no difference concerning the quality of analgesia.10
In another double-blind randomized study presented by Blay et.al, the hypothesis of ITM
efficiency in lowering intraoperative and postoperative opioid requirements of elderly patients
undergoing abdominal aortic surgery during the first 48 hours is explored. A total of forty-two
patients were recruited and enrolled over 12 months for the trial. Ten patients dropped from the
test due to refusal and ITM contraindications.11 Thirty-two patients were randomized to 2 groups,
(1) ITM group (General anesthesia with ITM), (2) Control Group (General Anesthesia alone),
one elimination from every group secondary to early death and violation of protocol. Ultimately,
the ITM group had 15 participants, and the Control group n=15.11 The patients were positioned
laterally for spinal anesthesia, landmarks L3-L4 or L4-L5 intervertebral space.11
The ITM group received 2 mls of diluted (0.1 mg/ml) morphine in the subarachnoid
space using a 27-gauge Whitacre needle. On the other hand, the Control group received a 2 ml
sterile saline subcutaneously.11 The interdisciplinary medical team was blinded to these
treatments. 11 General anesthesia induction was standardized with these patients, propofol (2
mg/kg) or sodium thiopentone (4 mg/kg), sufentanil (0.1 µg/kg), and atracurium (0.6 mg/kg) to
facilitate orotracheal intubation.11 Anesthesia was maintained with nitrous oxide, sevoflurane
(0.6% to 1%), and atracurium (0.3 mg/kg/h).11 Sufentanil was administered intravenously by a
continuous infusion (0.2 to 0.5 µg/kg/h). Dosing for sufentanil and sevoflurane were titrated to
need and hemodynamic stability.11 ASA standard monitoring was followed, inclusive of placing
an arterial line, central venous catheter and a foley catheter.11 All patients in both groups were
admitted in the ICU (Intensive Care Unit) for 24-48 hours.11 VAS was utilized to assess their
pain at rest and on coughing every 4 hours during the first 12 hours until 48 hours. The key
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finding of this study has shown that low-dose ITM administered preoperatively is significantly
helpful in diminishing the need for supplementary morphine for elderly patients after elective
abdominal aortic surgery.11
Wan et al., on the other hand sought to compare the analgesic effects of ITM and
epidural bupivacaine for patients undergoing elective abdominal hysterectomy. As a singleblinded study, the patient and principal investigator is aware of the intervention because it is
generally done when the patient is still awake.12 Thirty-two patients were enrolled, with ages
ranging 18-60 years old and ASA class I-II, randomly divided into two groups via a computergenerated table of numbers equating to even-sized groups. 12 Group ITM for intrathecal
morphine and Group EB (Epidural Bupivacaine). 12
Patients were premedicated with oral midazolam (7.5 mg) the night prior to the
procedure.12 Standard monitors are applied and observed; both interventions precede induction of
general anesthesia.12 Group ITM got a single injection of intrathecal morphine (0.2 mg) with 2.5
mL of 0.5% bupivacaine using a 25 G spinal needle, whilst group EB was given the study drug
after the epidural catheter is inserted.12 The loss of resistance technique was demonstrated with
an 18 G Touhy needle, testing with 3 mL lidocaine (2%) + adrenaline (1:200,000), and injected
via the catheter to confirm placement.12 Group EB received an aggregate 12 mL of 0.25% plain
bupivacaine as an intermittent bolus over 15 min before induction of anesthesia.12 Induction
medications constituted of IV fentanyl (2 µg/kg) and IV propofol (2 mg/ kg) for tracheal
intubation and muscle relaxation rocuronium (0.9 mg/kg) was used.12 With minimal flow
ventilation, anesthesia was then maintained with sevoflurane in a 30%–40% oxygen: air mixture.
12

Intra-operatively, analgesia for group EB was continued with an epidural infusion of 0.1%

bupivacaine + fentanyl (2 µg/ mL) at flow rates of 6–12 mL/hr.12
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This study concluded that group ITM had excellent pain control, evidenced by lesser
VAS scores in the first few hours of surgery. 12 Patients tolerated movements and ambulated
earlier. There were also fewer rescue analgesia needs when compared with the EB group.12
Conclusion
Opioids are highly potent centrally acting analgesic drugs for the treatment of pain and
Morphine is one the most common used opioids given intravascular or intrathecal. The series of
RCTs included in this literature review all yielded the same primary and secondary outcomes.
Fares et al., and Hein et al., conducted a study with a varying dose of morphine used, they proved
that 0.2 mg and 0.5 mg of ITM is enough to achieve good clinical analgesia and its positive
outcomes. Blay et al., compared a control group (General Anesthesia only) with the ITM group
(General Anesthesia with ITM), the ITM group showed better results when it comes to requesting
rescue analgesia postoperatively. Wan et al., contrasted ITM and epidural bupivacaine (EB), ITM
was superior in lessening the VAS scores and rescue morphine consumption. In the setting of ITM
administration, it is very effective in opioid sparing for the first 24-48 hours post-surgery. The
ideal dose of ITM is a balance between the opposing demands of providing the best possible
analgesia while curtailing dose-related undesirable effects.
IMPLEMENTATION
Primary Project Objective
Adequate analgesia is essential for patient recovery after major abdominal surgery.
Acute postoperative pain is a complex, physiological reaction to tissue injury. It remains a
challenge for anesthesia providers and health care practitioners to create a balanced multimodal
approach to treat it. Ineffective management such as undertreatment and overtreatment of
postoperative pain leads to poor patient outcomes. Anesthesia providers such as Certified
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Registered Nurse Anesthetists (CRNAs) and Anesthesiologists have employed various methods
to cater to this problem. Currently, the evidence-based practice for a multimodal approach in
postoperative pain for major abdominal surgery patients includes a peripheral nerve block known
as TAP Block and administering gabapentin and Tylenol preoperatively.
The primary goal of this Doctor of Nursing Project (DNP) is to identify methods to deliver
better postoperative analgesia for patients undergoing major abdominal surgery and provide an
educational tool that includes planning, implementation, and evaluation modules. Emerging as a
favorable option in clinical practice is the use of Intrathecal Morphine (ITM) before induction of
general anesthesia. It is a simpler and quicker neuraxial technique with a lower rate of failure. This
scholarly project aims to guide and translate evidence into practice by assessing the needs and
educating anesthesia providers regarding the efficacy of ITM.
Setting and Participants
Recruitment
The educational tool for ITM will comprise an interdisciplinary team. Therefore, it is
crucial to obtain support from stakeholders. The groundwork study will involve anesthesia
providers such as Certified Registered Nurse Anesthetists (CRNAs) and Anesthesiologists. The
anticipated sample size will be between 10-15 participants. These participants will be pulled
from the Mount Sinai Medical Center (MSMC) list of anesthesia providers. The quality
improvement (QI) tool framework will be presented in an online survey and a PowerPoint
presentation module with the members of the Anesthesia Department from Miami Beach
Anesthesiology Associates (MBAA) at MSMC. This quality improvement educational tool will
be concrete, detailed, and well-defined to meet the project purpose.
Description of Approach and Project Procedures
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The proposed project will be introduced in an online module to MBAA providers that
focus on the perioperative management of patients scheduled for major abdominal surgery.
The current information and understanding of the anesthesia provider will be specified using a
pre-evaluation tool that will influence the intervention's information and determine the content or
subject matter of the intervention. A pre-assessment test will establish this baseline information.
The second part will be a PowerPoint presentation through Zoom. A voiceover
PowerPoint regarding the use of ITM in patients undergoing major abdominal surgery will be
presented. Anesthesia providers' education is crucial in linking existing gaps in knowledge and
supporting the need for additional tools to ensure patients are provided evidence-based care
during the perioperative period. The presentation method will offer providers insight into the
importance of ITM use during the perioperative period to minimize postoperative opioid
consumption.
The next phase of this QI tool will entail an online post-assessment test to evaluate
the anesthesia providers learned knowledge and observation regarding the intervention.
The provider's feedback regarding the contents of the educational module delivered will
determine how this will impact their daily practice.

Protection of Human Subjects
Anesthesia providers participating in the survey will remain anonymous, and the
investigator will secure the data using unique code identifiers. In addition, a password and
spyware-protected laptop will be utilized to ensure the safekeeping of the information collected.
The providers willing to participate will be asked to sign an informed consent, and there will be
no untoward risks expected with the study as it will only require time spent by each anesthesia
provider in the educational module.
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DATA COLLECTION AND ANALYSIS
Quality Improvement Tool
The online survey will include a preassessment and post-assessment test to establish the
influence of the educational module presented. These tests will be conducted employing surveys
through Qualtrics. The planned survey will consist of 10 questions that will emphasize knowledge
and practice. In addition, there will be a means of measurement and comparison. The
preassessment questions will assess baseline understanding, whereas the post assessment will
define the participant's knowledge from the educational module and determine if it is beneficial in
daily practice. The study results will be kept confidential, and the patient's information will remain
anonymous throughout the study.
Data Management and Measure
The Doctor of Nursing Practice (DNP) student conducting the educational module will be
the primary investigator and responsible for disseminating the QI tool to the MBAA anesthesia
providers. Every question will be measured and will document answers to distinguish the
knowledge base before and after the educational module. The confidentiality of patients'
demographics will be maintained during the study. The impact of the QI tool on the provider's
practice will be established by the results of the pre-and post-test survey instruments. Analyzing
the pre- and post-assessment results will likely identify patterns that will be used to determine
the effectiveness of the educational module and if the module will improve anesthesia providers'
knowledge.
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IMPLEMENTATION RESULTS AND DISCUSSION
Pre/Post-Test Demographics
The pre-test demographics are shown in Table 2, displayed below.
Table 2: Pre-Test Participants Demographics
Demographic

N=10 (100 %)

Gender
Male

6(60%)

Female

4(40%)

Age
25-35

5(50%)

36-45

5(50%)

46-55

0 (0%)

56-66

0 (0%)

Ethnicity
Hispanic

2(20%)

Caucasian

3(30%)

African American

0(0%)

Asian

0(0%)

Other

5(50%)

Position/Title
CRNA

8(80%)

MD/DO

2(20%)

Years of Experience
1 to 2 years

2(20%)

2 to 5 years

3(30%)

5 to 10 years

3(30%)

More than 10 years

2(20%)
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There were 10 participants in the pre-test demographics. Most of the participants were
male (n=6, 60%) and female (n=4, 40%). There were also a range of ethnicities represented:
Caucasian (n=3, 30%), Hispanic (n=2, 20%), and other (n=5, 50%). Information was obtained
regarding the participant's role at the clinic. It was found that 80% (n= 8) participants were
CRNAs and the rest (n=2) 20 % are medical anesthesiologists. The participants were asked about
the tenure of time practicing, finding that the practice period ranged: less than one year (n=1,
20%), 1 to 5 years (n=2, 40%), and more than 10 years (n=2, 40%). The participants consisted of
DNP-prepared CRNAs (n=8, 60%), MD/DO (n=2, 20%).
Discussion
Pre-Test Confidence in Utilizing Single-shot Intrathecal Morphine in Minimizing
Postoperative Opioid Requirement in Abdominal Surgery Patients
The pre-test contained information regarding the utilization of single shot intrathecal
morphine in minimizing postoperative opioid requirement in abdominal surgery patients. The
majority of the participants (n=10, 100%) felt confident managing a patient undergoing
abdominal surgery in the perioperative period. The survey concluded that most participants often
(n=9, 90%) employ multimodal analgesia to minimize postoperative opioid requirement in
abdominal surgery patients. Of this n=9 or 90%, n=10 or 100 % incorporates the use of a
peripheral nerve block (TAP block) and preoperative oral Tylenol and Gabapentin.
Pre-Test Identification of Current Knowledge about Single-shot Intrathecal Morphine in
Minimizing Postoperative Opioid Requirement in Abdominal Surgery Patients
The survey focuses on identifying the benefits of an evidence based educational module
in utilizing single shot intrathecal morphine for patients undergoing major abdominal surgery.
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The participants know that Morphine is the first opiate given intrathecally; the question was
correctly answered by all participants (n=10, 100%). When asked about what dose is intrathecal
morphine deemed effective, all six participants answered the questions correctly (n=6, 60%).
Eight participants (n=8, 80%) Correctly answered the question regarding the duration of
intrathecal morphine analgesia.
80 % or n=8 participants agreed that utilizing intrathecal morphine for post operative pain relief
is cost effective, moderately safe and a reliable technique with low risk of technical failure.
The participants were asked questions involving the pharmacokinetics and pharmacodynamics
of Morphine, and scores generally improved when comparing pre- and post- test.
Table 3 shows the difference in responses from the pre- to post-test.

Table 3. Difference in Pre- and Post-Test Knowledge
Questions

Pre-test

Post- test

Results Difference

What is the first reported opiate given intrathecally?

100%

100%

0%

At what dose is intrathecal morphine deemed effective?

60%

100%

40%

What is the duration of intrathecal morphine analgesia?

80%

100%

20%

The effective site of action for morphine and other opiates is

80%

100%

20%

100%

100%

0%

achieved where?

According to studies, utilizing intrathecal morphine for post
operative pain relief is cost effective, moderately safe and a
reliable technique with a low risk of technical failure?
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Table 4. Utilization of Single Shot Intrathecal Morphine for Major Abdominal Surgery
Patients and its role in Minimizing Postoperative Opioid Consumption

How likely are you to use ITM to minimize
postoperative opioid requirement in patients
undergoing abdominal surgery?

Pre-test

Post-test

Difference

30%

100%

70%

Table 4. shows the educational module changes in participants' perspectives in utilizing
single shot intrathecal morphine when comparing the pre-test and post-test scores. The results
suggest that the narrated PowerPoint presentation provided the necessary educational
information, leading CRNAs to feel inclined to incorporate intrathecal morphine as part of a
multi modal therapy to reduce postoperative opioid consumption.
Post-Test Confidence in the Reduction of Postoperative Opioid Requirements of Major
Abdominal Surgery Patients by Utilizing a Single Shot Intrathecal Morphine
Participants were very confident (n=9, 90%) or somewhat confident (n=1, 10%) in
managing a patient utilizing single shot intrathecal morphine after completing the educational
module. When asked how often the participant had a patient in the perioperative period who
received intrathecal morphine, the majority selected rarely (n=9, 90%) compared to sometimes
(n=1, 10%).
Limitations
Limitations of the study include the small sample size; the online educational module and
survey were emailed to the anesthesia providers of Miami Beach Anesthesiology Associates
(MBAA) at Mount Sinai Medical Center. There were 43 emails on the list, and only ten people
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completed the survey. A larger sample size is ideal for detecting a statistically significant
difference in the findings and one that would reflect MBAA anesthesia practitioners. In addition,
the Qualtrics link, which included a voice-over PowerPoint presentation, pre-test, and post-test,
was sent online and was only accessible for two weeks; extending the time frame in which the
link can be accessed may have yielded more responses. Lastly, the project was disseminated and
completed entirely online, inhibiting it from being distributed through other means.
Summary
After the Zoom PowerPoint presentation, scores increased on the post-test from the
baseline pre-test scores. Most participants improved their knowledge about the benefits of
utilizing intrathecal morphine in reducing post-operative opioid consumption for major
abdominal surgery patients, n=9 or 90%. The participants that completed the survey yielded a
positive attitude towards implementing ITM for patients undergoing major abdominal surgery.
Therefore, the results of this QI project can guide MBAA anesthesia providers to weigh the
benefits and potential side effects of utilizing ITM in their practice. Ultimately achieving the
goal of providing enough pain management with reduced opioid consumption postoperatively
and promoting better patient outcomes.
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Appendix B
Project Questionnaire with Answers

Pretest and Posttest Questionnaire:
An Evidence Based Educational Module on the Efficacy of Single-shot Intrathecal
Morphine in Minimizing Postoperative Opioid Requirement in Abdominal Surgery
Patients: A Quality Improvement Project
INTRODUCTION
The primary aim of this QI project is to enhance the knowledge of anesthesia providers in
minimizing postoperative opioid requirement in abdominal surgery patients by utilizing single
shot intrathecal morphine (ITM) as part of a multimodal anesthesia plan.
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format and are meant to measure knowledge and perceptions on
intrathecal morphine.

PERSONAL INFORMATION
1. Gender: Male ____

Female______

non-Binary________

2. Age: ______
3. Ethnicity:
Hispanic

Caucasian

African American

4. Position/Title: _________________________________
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Asian Other_______________

5. Level of Education: Associates

Bachelors

Masters

___________
6. How many years have you been an anesthesia provider?
Over 10

5-10 years

2-5 years
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1-2 years

Other

Questionnaire
1. How confident do you feel managing a patient undergoing abdominal surgery in
the perioperative period?
a. Very confident
b. Somewhat confident
c. Somewhat unconfident
d. Not confident at all
2. How often do you use multimodal analgesia to minimize postoperative opioid
requirement in abdominal surgery patients?
a. Often
b. Sometimes
c. Rarely
d. Never
3. If you employ a multimodal anesthetic plan for balanced analgesia, what do you
utilize?
a. I don’t practice a multimodal technique
b. TAP block
c. Tylenol and Gabapentin orally given preoperatively
d. B and C as part of ERAS protocol
4. What is the first reported opiate given intrathecally?
a. Hydromorphone
b. Fentanyl
c. Morphine
Correct Answer: C. Morphine
5. How available is ITM in your facility?
a. It is easily accessible and available
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b. I have never heard of ITM use
6. At what dose is ITM deemed effective?
a. 0.7 mg
b. 0.2-0.5 mg
c. 1,000 mcg
Correct Answer: B. 0.2-0.5 mg
7. What is the duration of ITM analgesia?
a. 30 minutes
b. 18-24 hours
c. 10 minutes
d. 72 hours
Correct Answer: D. 18-24 hours
8. The effective site of action for morphine and other opiates is achieved where?
a. Dorsal Horn
b. Ventral Horn
c. Brain Stem
Correct Answer: A. Dorsal Horn
9. According to studies utilizing ITM for postoperative pain relief is cost-effective,
moderately safe and a reliable technique with low risk of technical failure? True
or False
a. True
b. False
Correct Answer: A. True
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10. How likely are you to use ITM to minimize postoperative opioid requirements in
patients undergoing abdominal surgery?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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